2019

Professional development Vacancies
2019
Regarding amendments to the instructions for medical use of medicinal products containing Etanercept, Golimumab, Infliximab

Dear applicants! The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (PRAC EMA), having reviewed the available evidence from the reviews provided by holders…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing Carbimazole, Thiamazole

Dear applicants! The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (PRAC EMA), based on the analysis of available sources (epidemiological data…

Read more
Regarding amendments to the instructions for medical use of medicinal products containing Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin

Dear applicants! The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (PRAC EMA) has reviewed the available evidence on a possible causal relationship…

Read more
Oxaliplatin

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the assessment of the analysis of Periodic Safety Update Reports (PSURs) and…

Read more
Voriconazole

The Pharmacovigilance Risk Assessment Committee (PRAC), on the basis of the assessment of the analysis of Periodic Safety Update Reports (PSURs) and the results of the evaluation…

Read more
Isotretinoin

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the assessment of the analysis of Periodic Safety Update Reports (PSURs) and…

Read more
Fenspiride

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the evaluation of the analysis of Periodic Safety Update Reports (PSURs) for…

Read more
Nadroparin

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the assessment of the analysis of Periodic Safety Update Reports (PSURs) and…

Read more
Fingolimod

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the assessment of the analysis of Periodic Safety Update Reports (PSURs) and…

Read more
Ciprofloxacin (systemic use)

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the evaluation of the analysis of Periodic Safety Update Reports (PSURs) for…

Read more